Lifecore Biomedical, Inc.

NASDAQ:LFCR

Drug Manufacturers - Specialty & Generic

Healthcare
$6.40 +0.27%

+$0.02 today

Market cap
$242.60M
Beta
1.07
P/E (TTM)
-6.1
EPS (TTM)
-$0.91
52W Low $3.63High $8.98

Volume 0.15M

Average 0.29M

LFCR Common Stock Issued

Cash raised by issuing new shares.

Lifecore Biomedical, Inc.NASDAQ: LFCR

Common Stock Issued · Q3 FY2026 · quarter ended Mar 2026

Common stock issued of $0 in Q3 FY2026

Q3 FY2026 common stock issued was $0. Trailing-twelve-month common stock issued was -$8K.

Context

  • Common stock issued amounted to 18.5% of revenue in FY2025, up 18.5 pp from a year earlier.
  • Common stock issued increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly common stock issued holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$2K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearMay 2025
$23.85M— YoY
LTMMar 2026
-$8K— YoY
Common Stock Issued past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Common Stock Issued history

USD · from the cash flow

Latest · FY2025
23.85M USD
Year-over-year change
—

Common Stock Issued vs competitors

How LFCR compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock issued is compared through growth and share of revenue rather than absolute size.
  • Common stock issued amounts to 0.0% of revenue for LFCR, versus a peer median of 2.8%.
LFCR Competitors
Common Stock Issued for LFCR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CGCCanopy Growth CorporationLTM Mar 2026CA$408.55M CAD+6.0%+609.2%130.8%
BIOABioAge Labs, Inc.LTM Mar 2026$143.89M USD+420.9%+640.5%1394.8%
ACHVAchieve Life Sciences, Inc.LTM Mar 2026$46.55M USD+183.0%+34.3%—
ACBAurora Cannabis Inc.LTM Mar 2026CA$9.94M CAD+1112.0%-48.6%3.2%
SGHTSight Sciences, Inc.LTM Mar 2026$1.89M USD+90.0%+14.0%2.4%
CVRXCVRx, Inc.LTM Mar 2026$937K USD-97.7%+139.0%1.6%
IMMPImmutep LimitedFY2025A$164.79K AUD-100.2%—3.3%
TKNOAlpha Teknova, Inc.LTM Mar 2026$144K USD-99.1%-21.7%0.3%
LFCRLifecore Biomedical, Inc.LTM Mar 2026$8K USD——0.0%
PRQRProQR Therapeutics N.V.LTM Mar 2026€1.71K EUR—-83.3%0.0%
Peer median (excluding LFCR) —+48.0%+24.1%2.8%

Competitors are the stored peer set for LFCR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
May 2021
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
Net Income(32.29M)(116.72M)(99.56M)12.01M(38.72M)
Depreciation & Amortization19.87M18.06M13.18M7.95M8.03M
Deferred Income Tax(7.87M)(6.83M)357K163K0
Stock-Based Compensation3.36M2.61M3.61M6.2M10.16M
Change in Working Capital9.76M(3.1M)19.79M(3.7M)(4.7M)
Accounts Receivables5.78M(6.14M)10.82M(2.39M)(2.26M)
Inventory(2.82M)(2.18M)(14.81M)862K7.69M
Accounts Payables(5.98M)9.34M16.04M(6.68M)(1.67M)
Other Working Capital12.79M(4.13M)7.74M4.51M(8.45M)
Other Non-Cash Items23.65M83.38M45.19M(22.38M)25.02M
Operating Cash Flow16.47M(22.59M)(17.44M)257K(206K)
Capital Expenditures(25.22M)(29.94M)(21.48M)(18.4M)(13.42M)
Acquisitions (Net)073.5M16.67M07M
Purchases of Investments00000
Sales of Investments045.1M000
Other Investing Activities12.91M(8.7M)000
Investing Cash Flow(12.31M)79.96M(4.81M)(18.4M)(6.42M)
Debt Repayment7.47M(55.41M)3.12M2.17M(18.56M)
Common Stock Issued004.82M023.85M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(10.89M)(1.61M)(6.32M)5.34M1.13M
Financing Cash Flow(3.42M)(57.02M)39.7M7.51M6.42M
Effect of Forex Changes00000
Net Change in Cash742K348K17.45M(10.63M)(197K)
Free Cash Flow(8.75M)(52.53M)(38.92M)(18.14M)(13.62M)

Lifecore Biomedical, Inc.

NASDAQ:LFCR

Intrinsic Alpha fair value

Locked

Current Price

$6.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.